Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase 1-2, Dose-Escalating, 4-Part Study to Evaluate the Safety and Pharmacokinetics of Single and Multiple Doses of AT-007 in Healthy Adult Subjects and Adult Subjects With Classic Galactosemia

NCT04117711 is registered in ClinicalTrials.gov with Applied Therapeutics, Inc. as lead sponsor.

NCT NCT04117711
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04117711 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase 1-2, Dose-Escalating, 4-Part Study to Evaluate the Safety and Pharmacokinetics of Single and Multiple Doses of AT-007 in Healthy Adult Subjects and Adult Subjects With Classic Galactosemia
Lead sponsor
Applied Therapeutics, Inc.
Phase
Phase 1/2
Overall status
Completed
Start date
June 21, 2019
Completion date
December 14, 2021
Enrollment
114 (actual)
Sites
4

Conditions

As the registry lists them; a condition with its own page is linked.

classic galactosemia